SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288: 17231727.
  • 2
    Morrison JA, James FW, Sprecher DL, Khoury PR, Daniels SR. Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975–1990: the Princeton School Study. Am J Public Health 1999; 89: 17081714.
  • 3
    Skelton JA, Cook SR, Auinger P., Klein JD, Barlow SE. Prevalence and trends of severe obesity among US children and adolescents. Acad Pediatr 2009; 9: 322329.
  • 4
    Freedman DS, Khan LK, Serdula MK, Ogden CL, Dietz WH. Racial and ethnic differences in secular trends for childhood BMI, weight, and height. Obesity (Silver Spring) 2006; 14: 301308.
  • 5
    Bhatt DL, Steg PG, Ohman EM et al; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180189.
  • 6
    Hinojosa MW, Varela JE, Smith BR, Che F., Nguyen NT. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg 2009; 13: 793797.
  • 7
    Buchwald H., Estok R., Fahrbach K. et al Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248256.e5.
  • 8
    Sendi P., Brunotte R., Potoczna N., Branson R., Horber FF. Health-related quality of life in patients with class II and class III obesity. Obes Surg 2005; 15: 10701076.
  • 9
    Herman KM, Craig CL, Gauvin L., Katzmarzyk PT. Tracking of obesity and physical activity from childhood to adulthood: The Physical Activity Longitudinal Study. Int J Pediatr Obes 2008; 18.
  • 10
    Coppini LZ, Bertevello PL, Gama-Rodrigues J., Waitzberg DL. Changes in insulin sensitivity in morbidly obese patients with or without metabolic syndrome after gastric bypass. Obes Surg 2006; 16: 15201525.
  • 11
    Morrison JA, Glueck CJ, Horn PS, Schreiber GB, Wang P.. Pre-teen insulin resistance predicts weight gain, impaired fasting glucose, and type 2 diabetes at age 18–19 y: a 10-y prospective study of black and white girls. Am J Clin Nutr 2008; 88: 778788.
  • 12
    Klein DJ, Friedman L. Aronson, Harlan WR et al Obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study. Diabetes Care 2004; 27: 378383.
  • 13
    Jiang X., Srinivasan SR, Radhakrishnamurthy B., Dalferes ER, Berenson GS. Racial (black-white) differences in insulin secretion and clearance in adolescents: the Bogalusa heart study. Pediatrics 1996; 97: 357360.
  • 14
    Srinivasan SR, Elkasabani A., Dalferes ER Jr, Bao W., Berenson GS. Characteristics of young offspring of type 2 diabetic parents in a biracial (black-white) community-based sample: the Bogalusa Heart Study. Metabolism 1998; 47: 9981004.
  • 15
    Friday KE, Srinivasan SR, Elkasabany A. et al Black-white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men. Metabolism 1999; 48: 749754.
  • 16
    Patel DA, Srinivasan SR, Xu JH, Chen W., Berenson GS. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2006; 55: 15511557.
  • 17
    Chen W., Srinivasan SR, Berenson GS. Path analysis of metabolic syndrome components in black versus white children, adolescents, and adults: the Bogalusa Heart Study. Ann Epidemiol 2008; 18: 8591.
  • 18
    Srinivasan SR, Myers L., Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 2002; 51: 204209.
  • 19
    Morrison JA, Glueck CJ, Wang P.. Preteen insulin levels interact with caloric intake to predict increases in obesity at ages 18 to 19 years: a 10-year prospective study of black and white girls. Metabolism 2010; 59: 718727.
  • 20
    Ventura AK, Loken E., Birch LL. Developmental trajectories of girls' BMI across childhood and adolescence. Obesity (Silver Spring) 2009; 17: 20672074.
  • 21
    Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study. Am J Public Health 1992; 82: 16131620.
  • 22
    Kimm SY, Glynn NW, Kriska AM et al Decline in physical activity in black girls and white girls during adolescence. N Engl J Med 2002; 347: 709715.
  • 23
    Morrison JA, Glueck CJ, Umar M. et al Hyperinsulinemia and metabolic syndrome at mean age of 10 years in black and white schoolgirls and development of impaired fasting glucose and type 2 diabetes mellitus by mean age of 24 years. Metabolism 2011; 60: 2431.
  • 24
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539553.
  • 25
    Nguyen QM, Srinivasan SR, Xu JH, Chen W., Berenson GS. Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study. Diabetes Care 2008; 31: 20442049.
  • 26
    Deshmukh-Taskar P., Nicklas TA, Morales M. et al Tracking of overweight status from childhood to young adulthood: the Bogalusa Heart Study. Eur J Clin Nutr 2006; 60: 4857.
  • 27
    Deshmukh-Taskar PR, O'Neil CE, Nicklas TA et al Dietary patterns associated with metabolic syndrome, sociodemographic and lifestyle factors in young adults: the Bogalusa Heart Study. Public Health Nutr 2009; 12: 24932503.
  • 28
    Arslanian SA, Saad R., Lewy V., Danadian K., Janosky J.. Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002; 51: 30143019.
  • 29
    Svec F., Nastasi K., Hilton C. et al Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes 1992; 41: 313317.
  • 30
    Williamson DF, Kahn HS, Byers T.. The 10-y incidence of obesity and major weight gain in black and white US women aged 30–55 y. Am J Clin Nutr 1991; 53: 1515S1518S.
  • 31
    Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 1995; 149: 10851091.
  • 32
    Mokdad AH, Ford ES, Bowman BA et al Diabetes trends in the U.S.: 1990–1998. Diabetes Care 2000; 23: 12781283.
  • 33
    Everhart JE, Pettitt DJ, Bennett PH, Knowler WC. Duration of obesity increases the incidence of NIDDM. Diabetes 1992; 41: 235240.
  • 34
    Wilson DM, Abrams SH, Aye T. et al; Glaser Pediatric Research Network Obesity Study Group. Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Arch Pediatr Adolesc Med 2010; 164: 116123.
  • 35
    Casazza K., Phadke RP, Fernandez JR et al Obesity attenuates the contribution of African admixture to the insulin secretory profile in peripubertal children: a longitudinal analysis. Obesity (Silver Spring) 2009; 17: 13181325.
  • 36
    Casazza K., Willig AL, Gower BA et al The role of European genetic admixture in the etiology of the insulin resistance syndrome in children: are the effects mediated by fat accumulation? J Pediatr 2010; 157: 5056.e1.
  • 37
    Hasson RE, Adam TC, Davis JN et al Ethnic differences in insulin action in obese African-American and Latino adolescents. J Clin Endocrinol Metab 2010; 95: 40484051.
  • 38
    Whincup PH, Nightingale CM, Owen CG et al Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study). PLoS Med 2010; 7: e1000263.
  • 39
    Lanctot JQ, Klesges RC, Stockton MB, Klesges LM. Prevalence and characteristics of energy underreporting in African-American girls. Obesity (Silver Spring) 2008; 16: 14071412.
  • 40
    Mosca CL, Marshall JA, Grunwald GK, Cornier MA, Baxter J.. Insulin resistance as a modifier of the relationship between dietary fat intake and weight gain. Int J Obes Relat Metab Disord 2004; 28: 803812.
  • 41
    Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473481.
  • 42
    Lustig RH, Mietus-Snyder ML, Bacchetti P. et al Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children. J Pediatr 2006; 148: 2329.
  • 43
    Lustig RH. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nat Clin Pract Endocrinol Metab 2006; 2: 447458.
  • 44
    Freedman DS, Khan LK, Serdula MK et al Racial differences in the tracking of childhood BMI to adulthood. Obes Res 2005; 13: 928935.
  • 45
    Yang X., Telama R., Leskinen E. et al Testing a model of physical activity and obesity tracking from youth to adulthood: the cardiovascular risk in young Finns study. Int J Obes (Lond) 2007; 31: 521527.
  • 46
    Love-Osborne K., Sheeder J., Zeitler P.. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr 2008; 152: 817822.
  • 47
    Davis JN, Kelly LA, Lane CJ et al Randomized control trial to improve adiposity and insulin resistance in overweight Latino adolescents. Obesity (Silver Spring) 2009; 17: 15421548.
  • 48
    Savoye M., Shaw M., Dziura J. et al Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA 2007; 297: 26972704.
  • 49
    Bingham SA, Gill C., Welch A. et al Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 1997; 26 Suppl 1: S137S151.
  • 50
    Freemark M., Bursey D.. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001; 107: E55.
  • 51
    Glueck CJ, Aregawi D., Winiarska M. et al Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2006; 19: 831842.
  • 52
    Glueck CJ, Wang P., Fontaine R., Tracy T., Sieve-Smith L.. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). J Adolesc Health 2001; 29: 160169.